71
A strong 2nd half helped finish FY2023 on a high note. Rising expenses reduced net margins but a positive NPAT after the first half was a good outcome. The problem shows in the cash flow though, negative OCF when right of use depreciation is backed out and once again its apparent the borrowings are paying the dividends. Poor capital allocation, should have suspended dividends rather than borrow to pay them. I think its time to sell.
[ You are not allowed to view attachments ]
[ You are not allowed to view attachments ]